Direct and Indirect Effectiveness of Influenza Vaccination Delivered to Children at School Preceding an Epidemic Caused by 3 New Influenza Virus Variants

Por Glezen, W. Paul, Gaglani, Manjusha J., Kozinetz, Claudia A., Piedra, Pedro A.
Publicado em 2010

Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons

Por Jackson, Lisa A, Gaglani, Manjusha J, Keyserling, Harry L, Balser, John, Bouveret, Nancy, Fries, Louis, Treanor, John J
Publicado em 2010

Live Attenuated Influenza Vaccine, Trivalent, Is Safe in Healthy Children 18 Months to 4 Years, 5 to 9 Years, and 10 to 18 Years of Age in a Community-Based, Nonrandomized, Open-La...

Por Piedra, Pedro A., Gaglani, Manjusha J., Riggs, Mark, Herschler, Gayla, Fewlass, Charles, Watts, Matt, Kozinetz, Claudia, Hessel, Colin, Glezen, W. Paul
Publicado em 2005

Efficacy of Trivalent, Cold-Adapted, Influenza Virus Vaccine Against Influenza A (Fujian), a Drift Variant, during 2003–2004

Por Halloran, M. Elizabeth, Piedra, Pedro A., Longini, Ira M., Gaglani, Manjusha J., Schmotzer, Brian, Fewlass, Charles, Herschler, Gayla B., Glezen, W. Paul
Publicado em 2007